Ditto Biosciences
PrivateLast Round
Seed
Jan 1, 2026
Total Funding Raised
$500,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ditto Biosciences is a biotechnology company that develops therapies for autoimmune diseases by leveraging an AI platform to discover drugs from parasite biology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ditto Biosciences Comparables
Compare Ditto Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Venomics AI Private Limited | 82% | |
| Myria Biosciences | 79% | |
| Evoquant LLC | 77% | |
Ditto Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 1, 2026 |
Ditto Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pioneer Fund | Seed |
| Y Combinator | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
$500K round led by Y Combinator
Ditto Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ditto Biosciences's valuation, stock price, and market status.